Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) GroupPfreundschuh, Michael ; Trümper, Lorenz ; Österborg, Anders ; Pettengell, Ruth ; Trneny, Marek ; Imrie, Kevin ; Ma, David ; Gill, Devinder ; Walewski, Jan ; Zinzani, Pier-Luigi ; Stahel, Rolf ; Kvaloy, Stein ; Shpilberg, Ofer ; Jaeger, Ulrich ; Hansen, Mads ; Lehtinen, Tuula ; López-Guillermo, Armando ; Corrado, Claudia ; Scheliga, Adriana ; Milpied, Noel ; Mendila, Myriam ; Rashford, Michelle ; Kuhnt, Evelyn ; Loeffler, MarkusThe lancet oncology, 2006-05, Vol.7 (5), p.379-391 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell LymphomaHabermann, Thomas M ; Weller, Edie A ; Morrison, Vicki A ; Gascoyne, Randy D ; Cassileth, Peter A ; Cohn, Jeffrey B ; Dakhil, Shaker R ; Woda, Bruce ; Fisher, Richard I ; Peterson, Bruce A ; Horning, Sandra JJournal of clinical oncology, 2006-07, Vol.24 (19), p.3121-3127 [Periódico revisado por pares]United States: American Society of Clinical OncologySem texto completo |
3 |
Material Type: Artigo
|
![]() |
Long-Term Results of the R-CHOP Study in the Treatment of Elderly Patients With Diffuse Large B-Cell Lymphoma: A Study by the Groupe d'Etude des Lymphomes de l'AdulteFEUGIER, P ; VAN HOOF, A ; GAULARD, P ; SALLES, G ; BOSLY, A ; GISSELBRECHT, C ; REYES, F ; COIFFIER, B ; SEBBAN, C ; SOLAL-CELIGNY, P ; BOUABDALLAH, R ; FERME, C ; CHRISTIAN, B ; LEPAGE, E ; TILLY, H ; MORSCHHAUSER, FJournal of clinical oncology, 2005-06, Vol.23 (18), p.4117-4126 [Periódico revisado por pares]Baltimore, MD: American Society of Clinical OncologySem texto completo |
4 |
Material Type: Artigo
|
![]() |
Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trialvan Oers, Marinus H.J. ; Klasa, Richard ; Marcus, Robert E. ; Wolf, Max ; Kimby, Eva ; Gascoyne, Randy D. ; Jack, Andrew ; van't Veer, Mars ; Vranovsky, Andrej ; Holte, Harald ; van Glabbeke, Martine ; Teodorovic, Ivana ; Rozewicz, Cynthia ; Hagenbeek, AntonBlood, 2006-11, Vol.108 (10), p.3295-3301 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic LeukemiaKEATING, Michael J ; O'BRIEN, Susan ; KOLLER, Charles ; WIERDA, William ; DETRY, Michelle A ; LYNN, Alice ; KANTARJIAN, Hagop ; ALBITAR, Maher ; LERNER, Susan ; PLUNKETT, William ; GILES, Francis ; ANDREEFF, Michael ; CORTES, Jorge ; FADERL, Stefan ; THOMAS, DeborahJournal of clinical oncology, 2005-06, Vol.23 (18), p.4079-4088 [Periódico revisado por pares]Baltimore, MD: American Society of Clinical OncologySem texto completo |
6 |
Material Type: Artigo
|
![]() |
Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study GroupHiddemann, Wolfgang ; Kneba, Michael ; Dreyling, Martin ; Schmitz, Norbert ; Lengfelder, Eva ; Schmits, Rudolf ; Reiser, Marcel ; Metzner, Bernd ; Harder, Harriet ; Hegewisch-Becker, Susanna ; Fischer, Thomas ; Kropff, Martin ; Reis, Hans-Edgar ; Freund, Mathias ; Wörmann, Bernhard ; Fuchs, Roland ; Planker, Manfred ; Schimke, Jörg ; Eimermacher, Hartmut ; Trümper, Lorenz ; Aldaoud, Ali ; Parwaresch, Reza ; Unterhalt, MichaelBlood, 2005-12, Vol.106 (12), p.3725-3732 [Periódico revisado por pares]United States: Elsevier IncTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
B cells move to centre stage: novel opportunities for autoimmune disease treatmentBrowning, Jeffrey LNature reviews. Drug discovery, 2006-07, Vol.5 (7), p.564-576 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
The Biological Activity of Human CD20 Monoclonal Antibodies Is Linked to Unique Epitopes on CD20Teeling, Jessica L ; Mackus, Wendy J. M ; Wiegman, Luus J. J. M ; van den Brakel, Jeroen H. N ; Beers, Stephen A ; French, Ruth R ; van Meerten, Tom ; Ebeling, Saskia ; Vink, Tom ; Slootstra, Jerry W ; Parren, Paul W. H. I ; Glennie, Martin J ; van de Winkel, Jan G. JJournal of Immunology, 2006-07, Vol.177 (1), p.362-371 [Periódico revisado por pares]United States: Am Assoc ImmnolTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Rituximab, an Anti‐CD20 Monoclonal Antibody: History and Mechanism of ActionPescovitz, M. D.American journal of transplantation, 2006-05, Vol.6 (5p1), p.859-866 [Periódico revisado por pares]Oxford UK: Blackwell Publishing LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphomaMarcus, Robert ; Imrie, Kevin ; Belch, Andrew ; Cunningham, David ; Flores, Eduardo ; Catalano, John ; Solal-Celigny, Philippe ; Offner, Fritz ; Walewski, Jan ; Raposo, Joäo ; Jack, Andrew ; Smith, PaulBlood, 2005-02, Vol.105 (4), p.1417-1423 [Periódico revisado por pares]Washington, DC: Elsevier IncTexto completo disponível |